Detailed View
AMRX - Amneal Pharmaceuticals, Inc.
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
5,924,515,840
Adj EBIT (TTM)
489,547,000
Enterprise Value
8,451,130,840
Last Price
17.01
Earnings Yield
5.79%
Return on Capital
28.60%
Capital
1,711,832,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 796,197,000 | 129,769,000 |
| 2026-03-31 | 10-Q | 2026 | 722,519,000 | 141,772,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 814,319,000 | 112,033,000 |
| 2025-09-30 | 10-Q | 2025 | 784,513,000 | 70,344,000 |
| 2025-06-30 | 10-Q | 2025 | 724,508,000 | 111,372,000 |
| 2025-03-31 | 10-Q | 2025 | 695,420,000 | 100,347,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 730,518,000 | 75,793,000 |
| 2024-09-30 | 10-Q | 2024 | 702,468,000 | 88,809,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.